Activities/News

• Informing about uveal melanoma
• Presenting our work and the importance of funding for uveal melanoma research also to be able to provide treatment for metastatic patients with no curative options today  
• Tebentafusp immunotherapy available in EU should also be accessible to Norwegian patients!

Links:
Hva er uvealt melanom (melanom.no)
Lær om uvealt melanom (brochure)

• Agate Noer oral presentation 2^nd of July “Spatial Transcriptomic Profiling of Paired Primary and Metastatic Uveal Melanoma Reveals EMT Immune Dichotomy”
• Henrik Jespersen poster presentation 3^rd of July  “Circulating Tumor DNA for Surveillance and Treatment Monitoring in Uveal Melanoma”

«Kreft I bevegelse: ctDNA som biomarkør for øyekreft».

Tina Galdal Tollefsen (left) and Bjørg Eva Lund (right) got an excellent grade A for their work!

Poster presentation of Bachelor project and research on «KREFT I BEVEGELSE: ctDNA som biomarkør for øyekreft» by Bjørg Eva Lund (left) and Tina Galdal Tollefsen (right)

Jovana Bisevac got her PhD (Philosophiae Doctor degree)  Friday 13th of March on the Thesis: 
“The limbal stem- and lens epithelial cell involvement in anterior segment diseases and treatment"
Main supervisor: Agate Noer, Co- supervisors: Morten C. Moe and Goran Petrovski

Trial lecture: "Alternative sources of limbal stem cells and their niche being explored for clinical applications"

The group actively disseminated its research at several international and national meetings, including the 28th EVER Congress in Florence, where the group presented two oral presentations and two posters.

At the EVER Congress, Vojtěch Haničinec was awarded the Best Poster Prize for the presentation:
“Circulating Tumor DNA as a Biomarker for Surveillance of Uveal Melanoma.”

At the Nordic Melanoma Meeting in Tromsø, the group presented new results on the development of transcriptomic atlas of uveal melanoma, highlighting ongoing collaborative efforts in melanoma research across the Nordic region.

The group also contributed to public engagement during Arendalsuka 2025, where Henrik Jespersen and Agate Noer gave a presentation titled “Uvealt melanom – en oversett og dødelig kreftform,” raising awareness about this rare but serious cancer.